Primary progressive multiple sclerosis
- PMID: 9217691
- DOI: 10.1093/brain/120.6.1085
Primary progressive multiple sclerosis
Abstract
Patients with multiple sclerosis who develop progressive disability from onset without relapses or remissions pose difficulties in diagnosis, monitoring of disease activity and treatment. There is a need to define the diagnostic criteria for this group more precisely and, in particular, to describe a comprehensive battery of investigations to exclude other conditions. The mechanisms underlying the development of disability and the role of MRI in monitoring disease activity in this clinical subgroup require elucidation, particularly in view of the lack of change on conventional imaging in the presence of continuing clinical deterioration. The prognosis is poor and there are currently no treatment trials for this form of the disease.
Similar articles
-
Relapses and progression of disability in multiple sclerosis.N Engl J Med. 2000 Nov 16;343(20):1430-8. doi: 10.1056/NEJM200011163432001. N Engl J Med. 2000. PMID: 11078767
-
Secondary progressive multiple sclerosis: the relationship between short-term MRI activity and clinical features.Brain. 1998 Feb;121 ( Pt 2):225-31. doi: 10.1093/brain/121.2.225. Brain. 1998. PMID: 9549501 Clinical Trial.
-
Natural history of multiple sclerosis: a unifying concept.Brain. 2006 Mar;129(Pt 3):606-16. doi: 10.1093/brain/awl007. Epub 2006 Jan 16. Brain. 2006. PMID: 16415308
-
Natural history of multiple sclerosis: risk factors and prognostic indicators.Curr Opin Neurol. 2007 Jun;20(3):269-74. doi: 10.1097/WCO.0b013e32812583ad. Curr Opin Neurol. 2007. PMID: 17495619 Review.
-
Natural history of multiple sclerosis: long-term prognostic factors.Neurol Clin. 2011 May;29(2):293-308. doi: 10.1016/j.ncl.2011.01.006. Neurol Clin. 2011. PMID: 21439442 Review.
Cited by
-
Disease activity in primary progressive multiple sclerosis: a systematic review and meta-analysis.Front Neurol. 2023 Nov 6;14:1277477. doi: 10.3389/fneur.2023.1277477. eCollection 2023. Front Neurol. 2023. PMID: 38020591 Free PMC article.
-
Alpha4 beta7 integrin controls Th17 cell trafficking in the spinal cord leptomeninges during experimental autoimmune encephalomyelitis.Front Immunol. 2023 Apr 18;14:1071553. doi: 10.3389/fimmu.2023.1071553. eCollection 2023. Front Immunol. 2023. PMID: 37143680 Free PMC article.
-
Arginine vasopressin hormone receptor antagonists in experimental autoimmune encephalomyelitis rodent models: A new approach for human multiple sclerosis treatment.Front Neurosci. 2023 Mar 14;17:1138627. doi: 10.3389/fnins.2023.1138627. eCollection 2023. Front Neurosci. 2023. PMID: 36998727 Free PMC article. Review.
-
Assessment of Multiple Sclerosis Patients' Knowledge and Behavioral Practice Regarding COVID-19 in Saudi Arabia.Cureus. 2022 Dec 21;14(12):e32781. doi: 10.7759/cureus.32781. eCollection 2022 Dec. Cureus. 2022. PMID: 36686104 Free PMC article.
-
Association between miRNA-145 and miRNA-155 expression in peripheral blood mononuclear cells of patients with multiple sclerosis: a case-control study.BMC Neurol. 2022 Nov 3;22(1):405. doi: 10.1186/s12883-022-02909-6. BMC Neurol. 2022. PMID: 36329419 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical